Heads up for those who are planning to use kratom
: The Drug Enforcement Agency (DEA) has recently issued an intention to categorize the active components of kratom as Schedule I controlled substances.
The compounds in question – mitragynine and 7-hydroxymitragynine – mimic the effects of opioid medication, leading kratom to become one of the most highly abused substances in recent times. Despite support from users due to the alleged therapeutic benefits of the drug, the DEA cited that the substances fall under Schedule I due to the following factors:
- No proof to be effective for any medical treatment
- No safety precautions for use, even under medical care
Kratom has figured in several cases of medical and even criminal cases in the U.S. According to a press release
by the DEA, more than 55,000 kilograms of kratom in various forms – capsules, powder, liquids, and patches – have been seized at U.S. entry ports between February 2014 and July of this year. This figure does not include at least 57,000 kilograms reported to be set for import into the country in the same time frame.
The health risks and toxicity of kratom have led the DEA and other federal agencies involved in the drug watch to consider the substance unfit for human use. Although the plant is popular in some parts of the world because of its pain-relieving and sedative effects, abuse of kratom
may lead to a wide array of health signs ranging from dryness in the mouth to delusion and schizophrenia.